文献速递心力衰竭与心肌病

T细胞在急性和慢性心肌炎中的作用:从诊断到治疗

T cells in acute and chronic myocarditis: from diagnosis to treatment.
PubMed 文献 · Eur Heart J · 2026-01-01

本综述整合现有心肌炎模型,提出以免疫耐受丧失为核心的统一免疫学概念,聚焦急性与慢性心肌炎的诊断和治疗。文章指出免疫检查点抑制剂相关心肌炎等新病因使T细胞耐受破坏成为关键机制,并展望心肌炎症性疾病未来的诊断与治疗研究方向。

要点

  • 免疫耐受丧失是心肌炎发病的核心机制,T细胞在其中起关键作用。
  • 免疫检查点抑制剂相关心肌炎等新病因拓展了心肌炎的病因谱。
  • 从免疫耐受视角整合急性与慢性心肌炎的诊断与治疗策略。

核心结论

  • 以免疫耐受丧失为统一框架可整合急性和慢性心肌炎的发病机制,并指导诊断与治疗。

研究设计与样本

  • 本综述将现有心肌炎模型整合为统一的免疫学概念,从免疫耐受丧失角度讨论诊断和治疗。

主要发现

  • 免疫检查点抑制剂相关心肌炎中T细胞耐受破坏被认定为疾病发展的关键机制。
  • 过去十年出现了免疫检查点抑制剂相关心肌炎以及与慢性炎症和遗传疾病相关的心肌炎等新病因。

临床怎么用

  • 临床应从免疫耐受丧失角度认识心肌炎,关注免疫检查点抑制剂相关心肌炎等新病因。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Myocarditis refers to infiltration of immune cells into the heart causing inflammation and cardiomyocyte damage. Clinically, myocarditis can be acute or chronic. While the clinical and pathological syndrome of myocarditis has been recognized for more than a century, newer aetiologies for myocarditis have emerged in the past decade. These include myocarditis associated with immune checkpoint inhibitors, or myocarditis linked to chronic inflammatory and genetic diseases. With the emergence of immune checkpoint inhibitor-associated myocarditis, the breakdown of T cell tolerance has been recognized as a key mechanism in disease development. The main focus of this review is to integrate existing models of myocarditis into an overarching immunological concept. Through the lens of loss of immune tolerance, this review focuses on diagnosis and treatment of myocarditis. Starting from acute myocarditis as paradigmatic inflammatory condition of the heart, this review outlines future research frontiers for myocardial inflammatory disease including new approaches to diagnosis and treatment.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Song EJ, Joachimbauer A, Tasca S, et al. T cells in acute and chronic myocarditis: from diagnosis to treatment. Eur Heart J. 2026. PMID: 41605248. doi:10.1093/eurheartj/ehaf1080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。